Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine.
暂无分享，去创建一个
Y. Okamoto | S. Yamazaki | M. Honda | A. Yamazaki | H. Yoshikura | S. Naganawa | K. Matsuo | K. Someya | S. Haga | Y. Chujoh | H. Yoshizaki | T. Nakasatomi